Click here for references

 

ELESTAT® ophthalmic solution is convenient to use. The recommended dosage is 1 drop in each eye twice a day. Please keep in mind that treatment should be continued throughout the period of exposure (until pollen season is over or until exposure to the offending allergen ends), even when symptoms are not present.





©2006 Inspire Pharmaceuticals, Inc., Durham, NC 27703 ® Marks owned by Allergan, Inc. Inspire and the Inspire logo are registered trademarks of Inspire Pharmaceuticals, Inc. ELESTAT® is licensed from Boehringer Ingelheim Pty. Ltd., Ingelheim, Germany.


ELESTAT® ophthalmic solution is approved for the prevention of ocular itching associated with allergic conjunctivitis.

Important Safety Information:
ELESTAT® ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to epinastine or to any of the other ingredients.
ELESTAT® is for topical ophthalmic use only and not for injection or oral use. The most frequently reported ocular adverse events occurring in approximately 1-10% of patients were burning sensation in the eye, folliculosis, hyperemia, and pruritus.

Please see Prescribing Information for ELESTAT®.